333
Views
27
CrossRef citations to date
0
Altmetric
Trends in Molecular Medicine

Molecular basis and diagnostics of hereditary colorectal cancers

&
Pages 379-388 | Published online: 08 Jul 2009

References

  • Burt RW. Colon cancer screening. Gastroenterology 2000;119: 837–53.
  • Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Eng J Med 2000;343:78–5.
  • Rozen P, Fireman Z, Figer A, Legum C, Ron E, Lynch HT. Family History of Colorectal-Cancer As a Marker of Potential Malignancy Within a Screening-Program. Cancer 1987; 60: 248–54.
  • Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S. Family history and colorectal cancer: predictors of risk. Cancer Causes Control 2003;14:879–87.
  • Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215–25.
  • Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a MutL homolog in hereditary colon cancer. Science 1994;263:1625–9.
  • Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, et al. Mutations of GTBP in genetically unstable cells. Science 1995;268:1915–7.
  • Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994371:75–80.
  • Wu Y, Berends MJW, Sijmons RH, Mensink RGJ, Verlind E, Kooi KA, et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 2001;29:137–8.
  • Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MRS, Morrison P, et al. Structure of the human MSH2 locus and analysis of 2 Muir-Torre kindreds for MSH2 mutations. Genomics 1994;24:516–526.
  • Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, et al. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet 1996;59:736–9.
  • Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, et al. The molecular basis of Turcot's syndrome. New Eng J Med 1995;332:839–47.
  • Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661–5.
  • Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 1992;51:92–100.
  • Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79–83.
  • Mori T, Nagase H, Horii A, Miyoshi Y, Shimano T, Nakatsuru S, et al. Germ-line and somatic mutations in the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer 1994;9:168–72.
  • Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G : C -> T : A mutations in colorectal tumors. Nat Genet 2002;30: 227–32.
  • Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086–8.
  • Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001;28:184–7.
  • Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jegheus syndrome. Nature 1998;391:184–7.
  • Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng ZM, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64–7.
  • Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 2003;72: 1308–14.
  • Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677–85.
  • Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Järvinen FU. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430–3.
  • Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome - rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 1981;141:607–11.
  • Chen CS, Loweinstein L, James C, Huilgol SC, Selva D. Muir-Torre syndrome and early detection of internal malignancy. Med J Aust 2003;178:368.
  • Kruse R, Rutten A, Schweiger N, Jakob E, Mathiak M, Propping P, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 2003;120:858–64.
  • Vasen HFA, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on hereditary nonpolypo-sis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424–5.
  • Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116: 1453–6.
  • Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and micro-satellite instability. J Natl Cancer Inst 2004;96:261–8.
  • Peltomäki P, Vasen H. Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/insight mutation database. Dis Markers 2004:In press.
  • Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174–9.
  • Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt R, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248–57.
  • Liu T, Yan H, Kuismanen S, Percesepe A, Bisgaard ML, Pedroni M, et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001;61:7798–802.
  • Kruse R, Rutten A, Lamberti C, Hosseiny-Malayeri HR, Wang YP, Ruelfs C, et al. Muir-Torre phenotype has a frequency of DNA mismatch repair gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998. 63:63–70.
  • Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995; 55: 5545–7.
  • Duval A, Iacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamelin R. Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene 1999;18:6806–9.
  • Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169–74.
  • Renkonen E, Zhang YG, Lohi H, Salovaara R, Abdel-Rahman WM, Nilbert M, et al. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003;21: 3629–37.
  • Herrera L, editor. Familial Adenomatous Polyposis. New York, NY: Alan R Liss Inc; 1990.
  • Bulow S, Bjork J, Christensen IJ, Fausa 0, Jarvinen H, Moesgaard F, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381–6.
  • Anthony T, Rodriguez-Bigas MA, Weber TK, Petrelli NJ. Desmoid tumors. J Am Coll Surg 1996;182:369–77.
  • Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721–33.
  • Bertario L, Russo A, Sala P, Eboli M, Giarola M, D'Amico F, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102–7.
  • Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Boker T, et al. Familial adenomatous polyposis - desmoid tumors and lack of ophthalmic lesions (CHPRE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995;4:337–40.
  • Lynch HT. Desmoid tumors: Genotype-phenotype differences in familial adenomatous polyposis - A nosological dilemma. Am J Hum Genet 1996;59:1184–5.
  • Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta-Rev Cancer 2003;1653:1–24.
  • Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3: 433–8.
  • Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000;18:1967–9.
  • Powell SM, Petersen GM, Krush A J, Booker S, Jen J, Giardiello FM, et al. Molecular diagnosis of familial adenomatous polyposis. New Eng J Med 1993;329:1982–7.
  • Moisio AL, Järvinen H, Peltomäki P. Genetic and clinical characterisation of familial adenomatous polyposis: a popula-tion based study. Gut 2002;50:845–50.
  • Spirio L, Nelson L, Ward K, Burt R, White R, Leppert M. A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 1993;52:286–96.
  • Lammi L, Arte S, Somer M, Järvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 2004; 74: 1043–50.
  • De Rosa M, Fasano C, Panariello L, Scarano MI, Belli G, Iannelli A, et al. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous muta-tions within the PMS2 gene. Oncogene 2000;19:1719–23.
  • Nicolaides NC, Littman SJ, Modrich P, Kinzler KW, Vogelstein B. A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 1998;18: 1635–41.
  • Leung SY, Yuen ST, Chan TL, Chan ASY, Ho JWC, Kwan K, et al. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene 2000;19:4079–83.
  • Burt RW. Gastric fundic gland polyps. Gastroenterology 2003;125:1462–9.
  • Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, et al. Genotype-phenotype correlations in patients with attenuated adenomatous polyposis coli. Gastroenterology 1998;114:A682–2.
  • Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003;2:43–55.
  • White S, Bubb V J, Wyllie AH. Germline APC mutation (Gln(1317)) in a cancer-prone family that does not result in familial adenomatous polyposis. Genes Chromosomes Cancer 1996;15:122–8.
  • Prior TW, Chadwick RB, Papp AC, Arcot AN, Isa AM, Pearl DK, et al. The 11307K polymorphism of the APC gene in colorectal cancer. Gastroenterology 1999;116:58–63.
  • Sieber 0, Lipton L, Heinimann K, Tomlinson I. Colorectal tumourigenesis in carriers of the APC 11307K variant: lone gunman or conspiracy? J Pathol 2003;199: 137–9.
  • Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Karja V, et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 2003;163: 827–32.
  • Fleischmann C, Peto J, Cheadle J, Shah B, Sampson J, Houlston RS. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer 2004;109:554–8.
  • Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003;362:39–41.
  • Järvinen H, Franssila KO. Familial juvenile polyposis coli - increased risk of colorectal cancer. Gut 1984;25:792–800.
  • Eng C. To be or not to BMP. Nat Genet 2001;28:105–7.
  • Friedl W, Uhlhaas S, Schulmann K, Stolte M, Loff S, Back W, et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 2002;111:108–11.
  • Jacoby RF, Schlack S, Cole CE, Skarbek M, Harris C, Meisner LF. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology 1997;112:1398–403.
  • Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998;280:1036–7.
  • Woodford-Richens K, Williamson J, Bevan S, Young J, Leggett B, Frayling I, et al. Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res 2000;60: 2477–82.
  • Giardiello FM, Welsh SB, Hamilton SR, Offerhaus G JA, Gittelsohn AM, Booker SV, et al. Increased Risk of Cancer in the Peutz-Jeghers Syndrome. New Eng J Med 1987;316:1511–4.
  • Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119: 1447–53.
  • Olschwang S, Boisson C, Thomas G. Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predis-posed to primitive biliary adenocarcinoma. J Med Genet 2001; 38:356–60.
  • Boardman LA, Couch FJ, Burgart LJ, Schwartz D, Berry R, McDonnell SK, et al. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat 2000;16:23–30.
  • Meur NL, Martin C, Saugier-Veber P, Joly G, Lemoine F, Moirot H, et al. Complete germline deletion of the STK11 gene in a family with Peutz-Jeghers syndrome. Eur J Hum Genet 2004;12: 415–8.
  • Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000;37:828–30.
  • Merks JHM, de Vries LS, Zhou XP, Nikkels P, Barth PG, Eng C, et al. PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet 2003;40:e111.
  • Lipton L, Fleischmann C, Sieber OA, Thomas HJW, Hodgson SV, Tomlinson IPM, et al. Contribution of the CHEK2 1100deIC variant to risk of multiple colorectal adenoma and carcinoma. Cancer Lett 2003;200:149–52.
  • Kilpivaara 0, Laiho P, Aaltonen LA, Nevanlinna H. CHEK2 1100deIC and colorectal cancer. J Med Genet 2003:40.
  • Jaeger EEM, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, et al. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 2003;72:1261–7.
  • Wiesner GL, Daley D, Lewis S, Ticknor C, Platzer P, Lutterbaugh J, et al. A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci USA 2003;100:12961–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.